XIAORONG RONALD ZHU to Male
This is a "connection" page, showing publications XIAORONG RONALD ZHU has written about Male.
Connection Strength
0.182
-
A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol. 2014 Sep 11; 9:202.
Score: 0.015
-
Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):846-53.
Score: 0.015
-
Uncertainty incorporated beam angle optimization for IMPT treatment planning. Med Phys. 2012 Aug; 39(8):5248-56.
Score: 0.013
-
Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose. Int J Radiat Oncol Biol Phys. 2011 Oct 01; 81(2):552-9.
Score: 0.012
-
A CT-based software tool for evaluating compensator quality in passively scattered proton therapy. Phys Med Biol. 2010 Nov 21; 55(22):6759-71.
Score: 0.012
-
Treatment planning system evaluation for mesothelioma IMRT. Lung Cancer. 2005 Jul; 49 Suppl 1:S75-81.
Score: 0.008
-
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors. Med Dosim. 2013; 38(3):344-50.
Score: 0.007
-
Evaluation of Kodak EDR2 film for dose verification of intensity modulated radiation therapy delivered by a static multileaf collimator. Med Phys. 2002 Aug; 29(8):1687-92.
Score: 0.007
-
Multiple-CT optimization of intensity-modulated proton therapy - Is it possible to eliminate adaptive planning? Radiother Oncol. 2018 07; 128(1):167-173.
Score: 0.005
-
Human papillomavirus status and the relative biological effectiveness of proton radiotherapy in head and neck cancer cells. Head Neck. 2017 04; 39(4):708-715.
Score: 0.005
-
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-367.
Score: 0.004
-
A Retrospective Evaluation of the Benefit of Referring Pediatric Cancer Patients to an External Proton Therapy Center. Pediatr Blood Cancer. 2016 Feb; 63(2):262-9.
Score: 0.004
-
A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):344-352.
Score: 0.004
-
Proton energy optimization and reduction for intensity-modulated proton therapy. Phys Med Biol. 2014 Nov 07; 59(21):6341-54.
Score: 0.004
-
Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):540-6.
Score: 0.004
-
Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):809-18.
Score: 0.004
-
Proton therapy for seminoma: Case report describing the technique, efficacy, and advantages of proton-based therapy for seminoma. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):135-40.
Score: 0.004
-
Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation. Radiat Oncol. 2013 Dec 17; 8:289.
Score: 0.004
-
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Dec 01; 87(5):946-53.
Score: 0.004
-
Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim. 2013; 38(4):390-4.
Score: 0.004
-
Statistical assessment of proton treatment plans under setup and range uncertainties. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):1007-13.
Score: 0.004
-
PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys. 2013 Feb; 40(2):021709.
Score: 0.003
-
Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol. 2012 Jul 07; 57(13):4095-115.
Score: 0.003
-
Fast range-corrected proton dose approximation method using prior dose distribution. Phys Med Biol. 2012 Jun 07; 57(11):3555-69.
Score: 0.003
-
Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1419-24.
Score: 0.003
-
Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate. Phys Med Biol. 2011 Aug 21; 56(16):5287-302.
Score: 0.003
-
Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol. 2010 Dec 07; 55(23):7135-47.
Score: 0.003
-
Verification of patient-specific dose distributions in proton therapy using a commercial two-dimensional ion chamber array. Med Phys. 2010 Nov; 37(11):5831-7.
Score: 0.003
-
Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1563-70.
Score: 0.003
-
Spot scanning proton beam therapy for prostate cancer: treatment planning technique and analysis of consequences of rotational and translational alignment errors. Int J Radiat Oncol Biol Phys. 2010 Oct 01; 78(2):428-34.
Score: 0.003
-
Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer. J Appl Clin Med Phys. 2009 Jan 27; 10(1):2875.
Score: 0.003
-
A procedure for calculation of monitor units for passively scattered proton radiotherapy beams. Med Phys. 2008 Nov; 35(11):5088-97.
Score: 0.003
-
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):620-9.
Score: 0.002
-
Reducing metal artifacts in cone-beam CT images by preprocessing projection data. Int J Radiat Oncol Biol Phys. 2007 Mar 01; 67(3):924-32.
Score: 0.002
-
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):143-51.
Score: 0.002
-
A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1998 Aug 01; 42(1):213-21.
Score: 0.001
-
Investigation of copper-PTSM as a PET tracer for tumor blood flow. Int J Rad Appl Instrum B. 1991; 18(7):807-11.
Score: 0.001